03:43 AM EDT, 03/13/2025 (MT Newswires) -- Tarsus Pharmaceuticals ( TARS ) said late Wednesday it has priced an upsized underwritten public offering of 2.8 million shares at $44.50 per share for gross proceeds of about $125 million.

Underwriters have been granted a 30-day option to purchase up to 421,348 additional shares.

The offering, which was upsized from the initial $100 million, is set to close Friday.